177 related articles for article (PubMed ID: 11702850)
1. Cholesterol lowering and the vessel wall: new insights and future perspectives.
Stulc T; Ceska R
Physiol Res; 2001; 50(5):461-71. PubMed ID: 11702850
[TBL] [Abstract][Full Text] [Related]
2. [New information on the pathophysiology of atherosclerosis].
Reiner Z; Tedeschi-Reiner E
Lijec Vjesn; 2001; 123(1-2):26-31. PubMed ID: 11379194
[TBL] [Abstract][Full Text] [Related]
3. Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points.
Kinlay S; Selwyn AP; Delagrange D; Creager MA; Libby P; Ganz P
Curr Opin Lipidol; 1996 Dec; 7(6):389-97. PubMed ID: 9117144
[TBL] [Abstract][Full Text] [Related]
4. [The effect of reduced cholesterol on coronary arteries].
Landmark K; Reikvam A
Tidsskr Nor Laegeforen; 1998 Oct; 118(24):3805-9. PubMed ID: 9816952
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of plaque stabilization].
Müller-Wieland D; Faust M; Kotzka J; Krone W
Herz; 1999 Feb; 24(1):26-31. PubMed ID: 10093010
[TBL] [Abstract][Full Text] [Related]
6. [The promise of statins].
Capurso A
Ital Heart J Suppl; 2001 Mar; 2(3):224-9. PubMed ID: 11307780
[TBL] [Abstract][Full Text] [Related]
7. Plaque stabilization: the role of lipid lowering.
Lee RT
Int J Cardiol; 2000 Jun; 74 Suppl 1():S11-5. PubMed ID: 10856768
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of atherosclerotic plaque during lipid lowering.
Müller-Wieland D; Kotzka J; Krone W
Curr Opin Lipidol; 1997 Dec; 8(6):348-53. PubMed ID: 9412775
[TBL] [Abstract][Full Text] [Related]
9. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
De Caterina R; Lenzi S
G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058
[TBL] [Abstract][Full Text] [Related]
10. [The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].
Chen H; Ren JY; Wu B; Liu X; Wang RJ; Li LJ; Luo Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):531-5. PubMed ID: 17711713
[TBL] [Abstract][Full Text] [Related]
11. The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
Plana JC; Jones PH
Curr Atheroscler Rep; 2001 Sep; 3(5):355-64. PubMed ID: 11487446
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
[TBL] [Abstract][Full Text] [Related]
13. Endothelium and acute coronary syndromes.
Liao JK
Clin Chem; 1998 Aug; 44(8 Pt 2):1799-808. PubMed ID: 9702989
[TBL] [Abstract][Full Text] [Related]
14. A macro and micro view of coronary vascular insult in ischemic heart disease.
Davies MJ
Circulation; 1990 Sep; 82(3 Suppl):II38-46. PubMed ID: 2203563
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol lowering and coronary artery disease: mechanisms of risk reduction.
Archbold RA; Timmis AD
Heart; 1998 Dec; 80(6):543-7. PubMed ID: 10065020
[No Abstract] [Full Text] [Related]
16. [Atherosclerosis].
Koga T; Sasaki J
Nihon Rinsho; 1999 Jul; 57(7):1614-9. PubMed ID: 10429466
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of acute coronary syndromes and the potential role of statins.
Dupuis J
Atheroscler Suppl; 2001 Feb; 2(1):9-14. PubMed ID: 11286155
[TBL] [Abstract][Full Text] [Related]
18. What have we learned about the biology of atherosclerosis? The role of inflammation.
Libby P
Am J Cardiol; 2001 Oct; 88(7B):3J-6J. PubMed ID: 11595192
[TBL] [Abstract][Full Text] [Related]
19. Role of endothelial dysfunction in coronary artery disease and implications for therapy.
Kinlay S; Ganz P
Am J Cardiol; 1997 Nov; 80(9A):11I-16I. PubMed ID: 9375937
[TBL] [Abstract][Full Text] [Related]
20. The role of lipid-lowering therapy in multiple risk factor management.
Esper RJ
Drugs; 1998; 56 Suppl 1():1-7; discussion 33. PubMed ID: 9740535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
